Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II registrational trial of onapristone in patients with recurrent or metastatic endometrial cancer.

Trial Profile

Phase II registrational trial of onapristone in patients with recurrent or metastatic endometrial cancer.

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 May 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Onapristone (Primary)
  • Indications Endometrial cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Arno Therapeutics
  • Most Recent Events

    • 16 May 2016 According to Arno Therapeutics media release, company closed this study. But the decision was not based on any safety or lack of efficacy signal and the Company will continue to provide onapristone to all patients currently enrolled in this trial on a compassionate use basis.
    • 16 May 2016 Status changed from recruiting to discontinued, as per Arno Therapeutics media release.
    • 30 Mar 2016 According to an Arno Therapeutics media release, status changed from planning to recruiting.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top